subscribeSubscribe
price-trendAsk Us
Xenon Pharma: Phase 2 Azetukalner Data In Depression At ASCP 2024

Xenon Pharma: Phase 2 Azetukalner Data In Depression At ASCP 2024
GLOBENEWSWIRE
28 May 2024
Share Share
Polarean`s Xenon MRI to be Featured at Upcoming ATS 2024 Conference

Polarean`s Xenon MRI to be Featured at Upcoming ATS 2024 Conference
GLOBENEWSWIRE
08 May 2024
Share Share
Xenon Q1 2024 Call/Webcast, Corporate Update

Xenon Q1 2024 Call/Webcast, Corporate Update
GLOBENEWSWIRE
02 May 2024
Share Share
Xenon finally finds a way forward with epilepsy win

Xenon finally finds a way forward with epilepsy win
Amy Brown EVALUATE
04 Oct 2021
Share Share
Xenon Announces Positive Topline Results from Phase 2b ‘X-TOLE’ Trial of XEN1101

Xenon Announces Positive Topline Results from Phase 2b ‘X-TOLE’ Trial of XEN1101
GLOBENEWSWIRE
04 Oct 2021
Share Share
Xenon finally finds a way forward with epilepsy win

Xenon finally finds a way forward with epilepsy win
Amy Brown EVALUATE
04 Oct 2021
Share Share
Xenon Announces Positive Topline Results from Phase 2b ‘X-TOLE’ Trial of XEN1101

Xenon Announces Positive Topline Results from Phase 2b ‘X-TOLE’ Trial of XEN1101
GLOBENEWSWIRE
04 Oct 2021
Share Share
Xenon to Participate at the William Blair Biotech Focus Conference 2021

Xenon to Participate at the William Blair Biotech Focus Conference 2021
GLOBENEWSWIRE
13 Jul 2021
Share Share
Neurocrine Biosciences and Xenon Pharmaceuticals Announce Agreement to Develop First-in-Class Treatments for Epilepsy

Neurocrine Biosciences and Xenon Pharmaceuticals Announce Agreement to Develop First-in-Class Treatments for Epilepsy
PR NEWSWIRE
03 Dec 2019
Share Share
Xenon’s Teva-partnered pain drug flunks another test

Xenon’s Teva-partnered pain drug flunks another test
Ben Adams FIERCE BIOTECH
27 Jun 2017
Share Share